Decision Diagnostics Corp (DECN)

[rawman]

(JULY 23, 2020) -- The company has narrowed potential US testing partners to two clinical trials organizations and allied laboratories and expects to announce its decision in the next few days. That organization will lead the clinical trials in the U.S. that DECN expects will be the final requirement to secure FDA emergency authorization.

WOW! THIS RECENT PR SOUNDS VAGUELY FAMILIAR!

(MARCH 16, 2020) -- We are awaiting release of blood samples from previously infected people in Daegu, Korea, so that we can complete testing and make a final report to the U.S. FDA so that we may secure our Emergency Waiver.

Almost 200 companies have been grant the so-called "Emergency Waiver", i.e. an Emergency Use Authorization (EUA), since Berman was pontificating about testing on March 16, 2020! It is now July 29, 2020 and still NOTHING from DECN!